Maryland State Retirement & Pension System acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 4,000 shares of the company's stock, valued at approximately $254,000.
A number of other institutional investors have also modified their holdings of TEM. KLP Kapitalforvaltning AS acquired a new position in Tempus AI during the 2nd quarter worth $998,000. SteelPeak Wealth LLC acquired a new position in Tempus AI during the 2nd quarter worth $363,000. NTV Asset Management LLC acquired a new position in Tempus AI during the 2nd quarter worth $2,797,000. QRG Capital Management Inc. acquired a new position in Tempus AI during the 2nd quarter worth $273,000. Finally, Clarity Capital Partners LLC grew its stake in Tempus AI by 65.1% during the 2nd quarter. Clarity Capital Partners LLC now owns 80,147 shares of the company's stock worth $5,093,000 after purchasing an additional 31,611 shares in the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In related news, CFO James William Rogers sold 7,528 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $561,965.20. Following the sale, the chief financial officer owned 138,473 shares in the company, valued at $10,337,009.45. This represents a 5.16% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the company's stock in a transaction that occurred on Thursday, September 25th. The stock was sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the sale, the chief executive officer owned 9,141,032 shares in the company, valued at approximately $699,837,409.92. This represents a 3.51% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 933,662 shares of company stock worth $68,070,993. 26.27% of the stock is owned by insiders.
Tempus AI Stock Performance
TEM opened at $89.87 on Wednesday. The stock has a market cap of $15.61 billion, a P/E ratio of -75.52 and a beta of 4.87. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The stock's 50 day simple moving average is $80.27 and its 200 day simple moving average is $65.36. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $104.32.
Tempus AI (NASDAQ:TEM - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company's revenue was up 89.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research firms recently commented on TEM. Morgan Stanley boosted their target price on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research note on Tuesday, August 12th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Tempus AI in a research report on Wednesday, October 8th. Piper Sandler reissued a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Needham & Company LLC reissued a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a report on Friday, August 8th. Finally, Guggenheim boosted their price target on Tempus AI from $80.00 to $95.00 and gave the company a "buy" rating in a research report on Friday, September 26th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $71.83.
View Our Latest Report on TEM
Tempus AI Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.